China Medical Technologies, Inc. (the "Company") is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology, and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders.
BEIJING, Aug 16, 2010 /PRNewswire via COMTEX/ --China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro
diagnostic ("IVD") company, today announced its unaudited financial results
for the first fiscal quarter ended June 30, 2010 ("1Q FY2010").
1Q FY2010 Highlights
-- Revenues decreased by 10.9% year-over-year to RMB186.2 million (US$27.5
million) but increased by 5.9% sequentially.
-- Net income was RMB33.7 million ...
BEIJING, July 15, 2010 /PRNewswire via COMTEX/ --China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro
diagnostic ("IVD") company, today announced that its HER-2 FISH probe has been
chosen to be used in a research project focusing on cancer targeted therapy
standardization, as well as early cancer detection and treatment, which is
sponsored by the Chinese Ministry of Health. One of the subjects of this
research project is to standardize th...
BEIJING, July 2, 2010 /PRNewswire via COMTEX/ --China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro
diagnostic ("IVD") company, today announced that it will report its unaudited
financial results for the first fiscal quarter ("1Q FY2010") ended June 30,
2010 before the U.S. market opens on August 16, 2010. The Company's 2010
fiscal year ends on March 31, 2011.
The Company's senior management will host an earnings conference call at
...
BEIJING, June 29, 2010 /PRNewswire via COMTEX/ --China Medical Technologies,
Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro
diagnostic ("IVD") company, today announced the recent publication of a large
sample study on the Company's SPR analyzer and related HPV DNA chip (the "SPR
System") for the detection of 16 high risk and 8 low risk genotypes of human
papillomavirus ("HPV"). The study tested specimens of 560 patients with
atypical squamous cells of undeter...
Stock Quote
September 2010
?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Sign up to receive e-mail alerts whenever China Medical Technologies, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
